Reaction Details Report a problem with these data
Target
Melanocortin receptor 4
Ligand
BDBM50268802
Substrate
n/a
Meas. Tech.
ChEMBL_523574 (CHEMBL997224)
IC50
2.5±n/a nM
Citation
 Qu, H; Cai, M; Mayorov, AV; Grieco, P; Zingsheim, M; Trivedi, D; Hruby, VJ Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor. J Med Chem 52:3627-35 (2009) [PubMed]  Article 
Target
Name:
Melanocortin receptor 4
Synonyms:
MC4-R | MC4R | MC4R_HUMAN | Melanocortin MC4 | Melanocortin receptor 4 (MC-4) | Melanocortin receptor 4 (MC4-R) | Melanocortin receptor 4 (MC4R)
Type:
Enzyme
Mol. Mass.:
36949.50
Organism:
Homo sapiens (Human)
Description:
P32245
Residue:
332
Sequence:
MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY
  
Inhibitor
Name:
BDBM50268802
Synonyms:
Ac-Nle-c[Asp-cis-4-guanidinyl-Pro-DNal(2')-Arg-Trp-Lys]-NH2 | CHEMBL502300
Type:
Small organic molecule
Emp. Form.:
C54H74N16O9
Mol. Mass.:
1091.2672
SMILES:
CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2C[C@@H](CN2C1=O)N=C(N)N)C(N)=O |r,wU:4.4,12.11,21.81,50.52,wD:25.25,39.41,65.73,67.77,(39.57,-47.74,;38.21,-47.02,;38.16,-45.48,;36.8,-44.75,;36.75,-43.21,;38.06,-42.4,;38,-40.86,;39.31,-40.04,;36.65,-40.13,;35.39,-42.49,;35.34,-40.95,;34.08,-43.3,;32.72,-42.58,;31.42,-43.39,;31.47,-44.93,;32.83,-45.65,;30.16,-45.74,;28.8,-45.02,;27.49,-45.83,;26.13,-45.1,;24.82,-45.91,;23.47,-45.19,;23.42,-43.65,;22.06,-42.92,;20.75,-43.74,;22.01,-41.38,;20.63,-40.65,;19.18,-41.16,;17.92,-40.26,;16.69,-41.18,;17.19,-42.65,;16.46,-44,;17.25,-45.3,;18.8,-45.26,;19.52,-43.91,;18.73,-42.62,;23.31,-40.57,;24.63,-40.8,;25.96,-41.59,;23.26,-39.03,;21.9,-38.31,;21.85,-36.77,;20.5,-36.04,;20.44,-34.5,;19.08,-33.78,;19.04,-32.24,;17.77,-34.59,;24.57,-38.22,;25.93,-38.94,;25.98,-40.48,;27.24,-38.13,;27.19,-36.59,;25.83,-35.86,;24.52,-36.68,;23.17,-35.96,;23.11,-34.42,;21.76,-33.69,;21.71,-32.15,;23.02,-31.33,;24.38,-32.07,;24.43,-33.61,;25.78,-34.33,;28.59,-38.85,;29.91,-38.05,;29.86,-36.5,;31.27,-38.78,;32.35,-37.67,;33.85,-38.07,;33.84,-39.61,;31.31,-40.3,;32.67,-41.04,;33.98,-40.22,;35.07,-37.14,;34.87,-35.61,;33.45,-35.01,;36.1,-34.67,;22.16,-46,;20.8,-45.28,;22.21,-47.54,)|
Structure:
Search PDB for entries with ligand similarity: